ABBV vs ABT
AbbVie Inc. vs Abbott Laboratories · Updated Sep 14, 2026
ABBV — 13 winsABT — 10 wins
Price Performance
ABBV +18.16%ABT -22.37%
Performance
| ABBV | ABT | |
|---|---|---|
| 1 Month | +3.48% | -7.58% |
| 3 Months | +14.52% | +14.33% |
| 6 Months | +14.22% | -5.22% |
| YTD | +12.66% | -18.19% |
| 1 Year | +21.63% | -22.32% |
| 3 Year | +76.78% | +1.61% |
| 5 Year | +129.79% | -19.54% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | +12.1% | +27.3% | +11.2% | -4.6% | +19.3% | +28.4% | +19.6% | -0.8% | -6.3% | +55.0% | +8.7% | -10.1% |
| ABT | -17.9% | +10.4% | +3.0% | +0.5% | -21.0% | +29.0% | +25.9% | +25.0% | +23.0% | +46.1% | -10.5% | +0.0% |
Valuation
| ABBV | ABT | |
|---|---|---|
| P/E Ratio | 126.22 | 28.55 |
| Forward P/E | 18.32 | 18.58 |
| PEG Ratio | 4.39 | 3.30 |
| P/S Ratio | 7.06 | 4.04 |
| P/B Ratio | 16.13 | 2.76 |
| EV/EBITDA | 24.41 | 20.51 |
Financials
| ABBV | ABT | |
|---|---|---|
| EPS (TTM) | $2.04 | $3.59 |
| Gross Margin | +83.54% | +56.28% |
| Operating Margin | +31.56% | +16.50% |
| Net Margin | +4.66% | +9.65% |
| ROE | +13.23% | +9.50% |
| ROA | +2.67% | +5.07% |
| Debt/Equity | 2.65 | 0.52 |
Growth
| ABBV | ABT | |
|---|---|---|
| Revenue Growth YoY | +12.43% | +7.78% |
| Revenue Growth QoQ | -9.72% | -2.57% |
| EPS Growth YoY | -45.83% | -18.24% |
| EPS Growth QoQ | -61.76% | -39.22% |
Technical
| ABBV | ABT | |
|---|---|---|
| RSI (14) | 51.95 | 32.85 |
| % From 20-Day SMA | -0.32% | -7.38% |
| % From 50-Day SMA | +1.14% | -2.66% |
| % From 200-Day SMA | +12.54% | -3.24% |
| % From 52-Week High | -3.76% | -25.12% |
| % From 52-Week Low | +34.95% | +25.05% |
Analyst Ratings
ABBV
Buy(37 analysts)
Strong SellHoldStrong Buy
Price Target
$287.08
+11.53% upside
ABT
Buy(32 analysts)
Strong SellHoldStrong Buy
Price Target
$123.64
+20.62% upside
Overview
| ABBV | ABT | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Devices |
| Exchange | NYSE | NYSE |
| Market Cap | $443.43B | $182.12B |
| Shares Outstanding | 1.77B | 1.73B |
| Avg Volume (10D) | 4.14M | 8.04M |
| Dividend Yield | 2.72% | 2.36% |
Frequently Asked Questions
Is ABBV or ABT a better buy right now?
Based on 23 comparable metrics, ABBV leads in 13 categories while ABT leads in 10. ABBV has a consensus analyst rating with 37 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, ABBV or ABT?
Over the past year, ABBV returned +21.63% compared to ABT's -22.32%. In the short term (1 month), ABBV returned +3.48% vs ABT's -7.58%.
Is ABBV or ABT more expensive?
ABBV trades at a P/E of 126.22 compared to ABT's 28.55. On a price-to-sales basis, ABBV trades at 7.06x vs ABT's 4.04x. Forward P/E: ABBV at 18.32 vs ABT at 18.58.
Which stock has higher growth, ABBV or ABT?
ABBV's revenue grew +12.43% year-over-year compared to ABT's +7.78%. EPS growth: ABBV at -45.83% vs ABT at -18.24%.
Do ABBV and ABT pay dividends?
ABBV pays a dividend with a yield of 2.72%. ABT pays a dividend with a yield of 2.36%.
Which stock do analysts prefer, ABBV or ABT?
ABBV has 37 analysts with a target price of $287.08 (+11.53% upside). ABT has 32 analysts with a target of $123.64 (+20.62% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.